CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 51 enrolled
Drug / intervention
Bronchodilators inhalationdrug
Likely dose
Bronchodilators inhalation 0.1mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01933984
NCT01933984N/ACompleted
CompareCT.gov

Individualized Dosing Schedule of Inhaled Bronchodilator for Endotracheally Intubated Chronic Obstructive Pulmonary Disease Patients

Shin-hwar Wu·interventional·Posted Sep 4, 2013·Updated Jul 21, 2020

In Brief

A clinical study evaluating Bronchodilators inhalation for Chronic Obstructive Pulmonary Disease. Completed, enrolled 51 participants across 1 site.

Detailed Summary

This study evaluates whether individualized dosing schedule of inhaled bronchodilator is more effective than fixed dosing in reducing airway resistance of intubated COPD patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Obstructive Pulmonary Disease
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedSep 4, 2013
Enrollment StartAug 1, 2013
Primary CompletionJan 31, 2019
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 12.8 years ago

Interventions

Bronchodilators inhalationdrug

Salmeterol/fluticasone (Seretide Evohaler) 4 puffs plus fenoterol (Berotec)(0.1mg/puff) 4 puffs inhalation when target airway resistance, measured every 8 hours, not met